SCHEMBL30920825

SCHEMBL30920825

COc1cc2c(cc1Cl)cc(C(=O)N(C)OC)n2S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ NOD2 Q9HC29 2/20 0.43
▸ NOD1 Q9Y239 2/20 0.43
▸ ALOX5 P09917 1/20 0.41
▸ ALDH3A1 P30838 1/20 0.40
▸ PPARG P37231 2/20 0.40
▸ PPARD Q03181 1/20 0.40
▸ ACLY P53396 2/20 0.38
▸ TSHR P16473 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ GAA P10253 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27246865 1.00 ALDH1A1 (0.45) ALDH1A1CYP3A4NOD2NOD1ALOX5
SCHEMBL30920116 0.86 NOD2 (0.47) ALDH1A1NOD2NOD1ALOX5ALDH3A1
SCHEMBL27247710 0.86 NOD2 (0.47) ALDH1A1NOD2NOD1ALOX5ALDH3A1
SCHEMBL18824208 0.78 NOD2 (0.47) ALDH1A1NOD2NOD1ALDH3A1PPARG
SCHEMBL10002626 0.69 NOD1 (0.61) ALDH1A1NOD2NOD1ALOX5ALDH3A1
SCHEMBL10003608 0.69 NOD2 (0.57) ALDH1A1NOD2NOD1ALOX5PPARG
SCHEMBL31335990 0.68 KDM4E (0.50) ALDH1A1NOD2NOD1TSHRKDM4E
SCHEMBL10003470 0.68 NOD2 (0.51) ALDH1A1NOD2NOD1ALOX5TSHR
SCHEMBL10003474 0.68 NOD1 (0.46) ALDH1A1NOD2NOD1ALOX5ALDH3A1
SCHEMBL10003065 0.68 ALOX5 (0.38) ALDH1A1NOD2NOD1ALOX5TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4601635-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF Maze Therapeutics, Inc. (US) 2025-08-20 — — EP disclosed
Send feedback